School of Medicine

During WashU Medicine’s 2026 Martin Luther King Jr. Commemoration Week, 22 faculty, staff and students were recognized with Drum Major Awards for embodying King’s work and words.

WashU Medicine researchers have shown in a new study that GLP-1 medications, typically used for diabetes and weight loss, may be effective at treating and preventing substance use disorders, from alcohol to cigarettes to opioids.

Four WashU researchers have been named senior members of the National Academy of Inventors: Rajan Chakrabarty, Vijay Ramani, Christina Stallings and Zhude Tu.

The 2026-28 Carol B. and Jerome T. Loeb Teaching Fellows at WashU Medicine have been named. They are Salim Chahin, MD (left), an associate professor of neurology, and Ram K. Rohatgi, MD, an assistant professor of pediatrics and of radiology.

A mobile app developed by WashU Medicine researchers is effective at helping patients with substance use disorder who are in unstable housing situations take steps toward recovery, a new study found.

The master’s program in biomedical data science and artificial intelligence is one of few such programs in the U.S. It offers a flexible curriculum, part-time enrollment and evening classes to accommodate working students.

A new study from researchers at WashU Medicine shows that chronic organ rejection may be triggered by the disruption of lymphatic vessels from the donor organ rather than an attack by the patient’s immune system.

A new study by WashU Medicine researchers shows in mice that the ketogenic diet, long known to help treat epilepsy, causes changes in brain cells, opening a potential pathway to targeted therapies.

Researchers at WashU Medicine have found a strong correlation between obesity in one or both parents during pregnancy and their child’s risk of developing a common liver disorder.

Machine learning researchers at Washington University in St. Louis used artificial intelligence to help with early detection of spinal cord disease.